Literature DB >> 16331649

Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited.

Charles E Chambers1, Michael D Eisenhauer, Lynn B McNicol, Peter C Block, William J Phillips, Gregory J Dehmer, Frederick A Heupler, James C Blankenship.   

Abstract

In the early years of diagnostic cardiac catheterization, strict sterile precautions were required for cutdown procedures. Thirteen years ago, when the original guidelines were written, the brachial arteriotomy was still frequently utilized, femoral closure devices were uncommon, "implantables," such as intracoronary stents and PFO/ASD closure devices, were in their infancy, and percutaneous valve replacement was not a consideration. In 2005, the cardiac catheterization laboratory is a complex interventional suite with percutaneous access routine and device implantation standard. Despite frequent device implantation, strict sterile precautions are often not observed. Reasons for this include a decline in brachial artery cutdown, limited postprocedure follow-up with few reported infections, limited use of hats and masks in televised cases, and lack of current guidelines. Proper sterile technique has the potential to decrease the patient infection rate. Hand washing remains the most important procedure for preventing infections. Caps, masks, gowns, and gloves help to protect the patient by maintaining a sterile field. Protection of personnel may be accomplished by proper gowning, gloving, and eye wear, disposal of contaminated equipment, and prevention and care of puncture wounds and lacerations. With the potential for acquired disease from blood-borne pathogens, the need for protective measures is as essential in the cardiac catheterization laboratory as is the standard Universal Precautions, which are applied throughout the hospital. All personnel should strongly consider vaccination for hepatitis B. Maintenance of the cardiac catheterization laboratory environment includes appropriate cleaning, limitation of traffic, and adequate ventilation. In an SCAI survey, members recommended an update on guidelines for infection control in the cardiac catheterization laboratory. The following revision of the original 1992 guidelines is written specifically to address the increased utilization of the catheterization laboratory as an interventional suite with device implantation. In this update, infection protection is divided into sections on the patient, the laboratory personnel, and the laboratory environment. Additionally, specific CDC recommendation sections highlight recommendations from other published guidelines.

Entities:  

Mesh:

Year:  2006        PMID: 16331649     DOI: 10.1002/ccd.20589

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  8 in total

1.  Hybrid stage I palliation for hypo-plastic left heart condition without a hybrid suite: suggestions for developing nations.

Authors:  S Anuradha; Raghavan Subramanyan; Ravi Agarwal; A Thomas Pezzella; K M Cherian
Journal:  Indian Heart J       Date:  2012-06-19

Review 2.  Management Principles for the Cardiac Catheterization Laboratory During the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Pandemic.

Authors:  Keshav R Nayak; Ryan C Maves; Timothy D Henry
Journal:  Interv Cardiol Clin       Date:  2022-03-28

3.  Peri-Operative Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Cardiac and Thoracic Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Sonia Bianchini; Laura Nicoletti; Sara Monaco; Erika Rigotti; Agnese Corbelli; Annamaria Colombari; Cinzia Auriti; Caterina Caminiti; Giorgio Conti; Maia De Luca; Daniele Donà; Luisa Galli; Silvia Garazzino; Alessandro Inserra; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Nicola Petrosillo; Giorgio Piacentini; Carlo Pietrasanta; Nicola Principi; Matteo Puntoni; Alessandro Simonini; Simonetta Tesoro; Elisabetta Venturini; Annamaria Staiano; Fabio Caramelli; Gaetano Domenico Gargiulo; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-04-21

4.  Right ventricle performances with echocardiography and 99mTc myocardial perfusion imaging in pulmonary arterial hypertension patients.

Authors:  Jie Liu; Lei Fei; Guang-Qing Huang; Xiao-Ke Shang; Mei Liu; Zhi-Jun Pei; Yong-Xue Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

5.  Personal Protective Equipment and Donning and Doffing Techniques in the Cardiac Catheterization Laboratory During the COVID-19 Pandemic: Insights From an Internet Search for Protocols.

Authors:  Justin Haloot; Omar Sheikh; Fatima Dollar; Heta Javeri; Hendre Jeannetta Fichardt; Gail Fernandes; Marlene Garcia; Anand Prasad
Journal:  Front Cardiovasc Med       Date:  2021-05-13

6.  The need for maximal sterile barrier precaution in routine interventional coronary procedures; microbiology analysis.

Authors:  Avi Peretz; Fabio Kuzniec; Diab Ganem; Nabeeh Salman; Dahud Qarawani; Offer Amir
Journal:  Eur J Med Res       Date:  2016-11-10       Impact factor: 2.175

Review 7.  Cardiac Implantable Electronic Device Infection: From an Infection Prevention Perspective.

Authors:  Sangeeta Sastry; Riaz Rahman; Mohamed H Yassin
Journal:  Adv Prev Med       Date:  2015-10-13

Review 8.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.